Asosiy kontentga oʻtish
AkademScholar
Muassasalar

Barcelona Institute for Global Health

Nom variantlari: BIGH · BIGH-CERCA · Institut de Salut Global de Barcelona · Instituto de Salud Global de Barcelona · ISGlobal

Davlat:
ES
ROR:
https://ror.org/03hjgt059
3
h-indeks
48
Iqtiboslar
25
Asarlar
39
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
013450510152020172018201920202021202220232024202520262017: Nashrlar 2, Iqtiboslar 02018: Nashrlar 5, Iqtiboslar 02019: Nashrlar 1, Iqtiboslar 02020: Nashrlar 1, Iqtiboslar 12021: Nashrlar 5, Iqtiboslar 12022: Nashrlar 1, Iqtiboslar 62023: Nashrlar 4, Iqtiboslar 62024: Nashrlar 0, Iqtiboslar 112025: Nashrlar 2, Iqtiboslar 112026: Nashrlar 1, Iqtiboslar 12

Iqtibos tarixi

0510152020172018201920202021202220232024202520262017: Iqtiboslar 02018: Iqtiboslar 02019: Iqtiboslar 02020: Iqtiboslar 12021: Iqtiboslar 12022: Iqtiboslar 62023: Iqtiboslar 62024: Iqtiboslar 112025: Iqtiboslar 112026: Iqtiboslar 12

Nashr tarixi

0134520172018201920202021202220232024202520262017: Nashrlar 22018: Nashrlar 52019: Nashrlar 12020: Nashrlar 12021: Nashrlar 52022: Nashrlar 12023: Nashrlar 42024: Nashrlar 02025: Nashrlar 22026: Nashrlar 1

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

0134520172018201920202021202220232024202520262017: h-indeks 02018: h-indeks 02019: h-indeks 02020: h-indeks 12021: h-indeks 12022: h-indeks 22023: h-indeks 22024: h-indeks 22025: h-indeks 22026: h-indeks 3

Eng koʻp iqtibos qilingan asarlar

  1. Advancing the global public health agenda for NAFLD: a consensus statement20211 iqtibos
  2. Improving clinical practice in primary care for the prevention and control of noncommunicable diseases: a multi-actor approach to two regional pilot projects in Kazakhstan20190 iqtibos
  3. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?20210 iqtibos
  4. A multinational Delphi consensus to end the COVID-19 public health threat20220 iqtibos
  5. Laboratory and free-living gait performance in adults with COPD and healthy controls20230 iqtibos
  6. Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies20250 iqtibos
  7. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis20250 iqtibos
  8. Testing the construct validity of real-world digital mobility outcomes in multiple sclerosis20260 iqtibos